Quantitative analysis of memantine in human plasma by gas chromatography/negative ion chemical ionization/mass spectrometry

J Mass Spectrom. 2002 May;37(5):477-80. doi: 10.1002/jms.303.

Abstract

A sensitive and specific method for the determination of memantine in human plasma is presented. Memantine was extracted from plasma and derivatized to the pentafluorobenzoyl derivative in a one-step procedure avoiding any sample concentration steps. Amantadine was used as an internal standard. The compounds were measured by gas chromatography/negative ion chemical ionization mass spectrometry without any further processing. Using this detection mode, the fragment ions at m/z 353 and 325 were obtained at high relative abundance. Calibration graphs were linear over the range 0.117-30 ng ml(-1). At the limit of quantification (LOQ), the inter-assay precision was 2.00% and the intra-assay variability was 3.22%. The accuracy at the LOQ showed deviations of -1.42% (intra-assay) and -2.47% (inter-assay). The method is rugged, rapid and robust and was applied to the batch determination of memantine during pharmacokinetic profiling of the drug.

Publication types

  • Evaluation Study
  • Validation Study

MeSH terms

  • Amantadine / blood
  • Antiparkinson Agents / blood*
  • Antiparkinson Agents / pharmacokinetics
  • Biological Availability
  • Blood Preservation
  • Calibration
  • Cryopreservation
  • Gas Chromatography-Mass Spectrometry / methods*
  • Humans
  • Memantine / blood*
  • Memantine / pharmacokinetics
  • Reference Standards
  • Reproducibility of Results
  • Sensitivity and Specificity
  • Specimen Handling
  • Spectrometry, Mass, Secondary Ion / methods*

Substances

  • Antiparkinson Agents
  • Amantadine
  • Memantine